VaxInnate
Cranbury, New Jersey, United States
About VaxInnate
VaxInnate is a vaccine company that focuses on developing cures for flu, malaria, dengue, papillomavirus, and respiratory syncytial virus. It specializes in the fields of healthcare, health diagnostics, and biotechnology. It was founded in 2002 and headquartered in Cranbury, New Jersey.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $10K – $50K
- Total funding: $132.5M
- Last round: Series Unknown (Sep 2015)
- Website: vaxinnate.com
- Phone: +1 609-860-2260
Industries & Categories
Biotechnology, Health Care, Health Diagnostics
Social Profiles
Canonical: https://fsome.com/organization/vaxinnate-2500184 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.